Detalhe da pesquisa
1.
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
J Transl Med
; 22(1): 43, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200582